The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events.

[1]  J. V. Vanden Heuvel,et al.  Interleukin-2 Suppression by 2-Arachidonyl Glycerol Is Mediated through Peroxisome Proliferator-Activated Receptor γ Independently of Cannabinoid Receptors 1 and 2 , 2006, Molecular Pharmacology.

[2]  R. Mangieri,et al.  Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide] , 2006, Journal of Pharmacology and Experimental Therapeutics.

[3]  Zhe Ding,et al.  Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats , 2006, Pharmacology Biochemistry and Behavior.

[4]  F. J. Caballero,et al.  Iodinated N-Acylvanillamines: Potential “Multiple-Target” Anti-Inflammatory Agents Acting via the Inhibition of T-Cell Activation and Antagonism at Vanilloid TRPV1 Channels , 2006, Molecular Pharmacology.

[5]  J. Redondo,et al.  Calcium-dependent expression of TNF-α in neural cells is mediated by the calcineurin/NFAT pathway , 2006, Molecular and Cellular Neuroscience.

[6]  A. Ottani,et al.  The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. , 2006, European journal of pharmacology.

[7]  A. Israël,et al.  Deciphering the pathway from the TCR to NF-κB , 2006, Cell Death and Differentiation.

[8]  G. Nomikos,et al.  Identification of a high-affinity binding site involved in the transport of endocannabinoids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  V. Marzo,et al.  Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis , 2005, Neurobiology of Disease.

[10]  D. Busija,et al.  Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[11]  L. de la Vega,et al.  Mechanisms of HIV-1 Inhibition by the Lipid Mediator N-Arachidonoyldopamine1 , 2005, The Journal of Immunology.

[12]  A. Basbaum,et al.  Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System* , 2005, Journal of Biological Chemistry.

[13]  S. Gaetani,et al.  Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation , 2005, Journal of Pharmacology and Experimental Therapeutics.

[14]  J. Cadet,et al.  Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Lairmore,et al.  Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes , 2004, Retrovirology.

[16]  L. Petrocellis,et al.  The endocannabinoid system and its therapeutic exploitation , 2004, Nature Reviews Drug Discovery.

[17]  A. Rao,et al.  Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. , 2004, Molecules and cells.

[18]  D. Fegley,et al.  Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Petrocellis,et al.  The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.

[20]  B. Fiebich,et al.  Immunosuppressive Activity of Endovanilloids: N-Arachidonoyl-Dopamine Inhibits Activation of the NF-κB, NFAT, and Activator Protein 1 Signaling Pathways 1 , 2004, The Journal of Immunology.

[21]  T. S. Kim,et al.  Inhibition of Interleukin-4 Production in CD4+ T Cells by Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Involvement of Physical Association between PPAR-γ and the Nuclear Factor of Activated T Cells Transcription Factor , 2003 .

[22]  L. de la Vega,et al.  The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase‐8‐dependent pathway , 2003, British journal of pharmacology.

[23]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[24]  G. Appendino,et al.  Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists , 2003, British journal of pharmacology.

[25]  G. Appendino,et al.  Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. , 2003, Molecular pharmacology.

[26]  M. Pender,et al.  Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects , 2002, Internal medicine journal.

[27]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Fresno,et al.  Protein Kinase Cζ Phosphorylates Nuclear Factor of Activated T Cells and Regulates Its Transactivating Activity* , 2002, The Journal of Biological Chemistry.

[29]  Michael T. Fisher,et al.  Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. , 2002, Blood.

[30]  A. Minassi,et al.  N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor. , 2002, Journal of medicinal chemistry.

[31]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[32]  T. Bisogno,et al.  Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. , 2002, Current pharmaceutical design.

[33]  L. Iversen,et al.  Cannabinoids: a real prospect for pain relief? , 2002, Current opinion in pharmacology.

[34]  A. Rice,et al.  Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[35]  H. Lassmann,et al.  Inflammation in the nervous system: The human perspective , 2001, Glia.

[36]  I. Graef,et al.  NFAT signaling in vertebrate development. , 2001, Current opinion in genetics & development.

[37]  M. Fresno,et al.  Cot Kinase Induces Cyclooxygenase-2 Expression in T Cells through Activation of the Nuclear Factor of Activated T Cells* , 2001, The Journal of Biological Chemistry.

[38]  A. Rao,et al.  Partners in transcription: NFAT and AP-1 , 2001, Oncogene.

[39]  A. Makriyannis,et al.  Endocannabinoids control spasticity in a multiple sclerosis model , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  K. Ueno,et al.  Acetaminophen-induced immunosuppression associated with hepatotoxicity in mice. , 2000, Research communications in molecular pathology and pharmacology.

[41]  C. Hillard,et al.  The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. , 2000, Chemistry and physics of lipids.

[42]  M. Hüll,et al.  Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cells , 2000, Neuropharmacology.

[43]  J. Qin,et al.  Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.

[44]  T. Bisogno,et al.  Endocannabinoids: new targets for drug development. , 2000, Current pharmaceutical design.

[45]  R. Spengler,et al.  Brain-derived TNFα: involvement in neuroplastic changes implicated in the conscious perception of persistent pain , 2000, Brain Research.

[46]  Taosheng Chen,et al.  Activation of Human T Lymphocytes Is Inhibited by Peroxisome Proliferator-activated Receptor γ (PPARγ) Agonists , 2000, The Journal of Biological Chemistry.

[47]  Sunhee C. Lee,et al.  Neuronal death in cytokine‐activated primary human brain cell culture: role of tumor necrosis factor‐α , 1999, Glia.

[48]  T. J. Nickola,et al.  Brain-derived TNFα mediates neuropathic pain , 1999, Brain Research.

[49]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[50]  J. Vane,et al.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Piomelli,et al.  Functional role of high-affinity anandamide transport, as revealed by selective inhibition. , 1997, Science.

[52]  A. Rao,et al.  Mechanisms of transactivation by nuclear factor of activated T cells-1 , 1996, The Journal of experimental medicine.

[53]  J. Economou,et al.  The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. , 1992, The Journal of biological chemistry.

[54]  V. Drvota,et al.  Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). , 1989, Prostaglandins.

[55]  G. Crabtree,et al.  Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.

[56]  A. Israël,et al.  Purification of KBF1, a common factor binding to both H‐2 and beta 2‐microglobulin enhancers. , 1987, The EMBO journal.

[57]  D. Stillman,et al.  Correlations between transcription of a yeast tRNA gene and transcription factor-DNA interactions. , 1984, The Journal of biological chemistry.

[58]  B. Andersen,et al.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. , 1974, Journal of immunological methods.

[59]  M. Huleihel,et al.  Involvement of tumor necrosis factor alpha in hippocampal development and function. , 2004, Cerebral cortex.

[60]  C. Foged,et al.  Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. , 2001, Molecular pharmacology.

[61]  Richard S Lewis,et al.  Calcium signaling mechanisms in T lymphocytes. , 2001, Annual review of immunology.

[62]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[63]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.